Olema Pharmaceuticals Q1 EPS $(0.52) Beats $(0.53) Estimate

Benzinga Newsdesk www.benzinga.com Negative 89.9%

Neg 89.9% Neu 0% Pos 0%

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.53) by 1.89 percent. This is a 44.44 percent decrease over losses of $(0.36) per share from the same period last year.